United Therapeutics (UTHR) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $544.33 +1.12%
Revenue Growth %: +1.5%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +1.5%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
